Related references
Note: Only part of the references are listed.Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individuals
Astrid Johannesson Hjelholt et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2x2 factorial, randomised, crossover study in human individuals
Astrid J. Hjelholt et al.
DIABETOLOGIA (2020)
The acute effects of growth hormone in adipose tissue is associated with suppression of antilipolytic signals
Katrine L. Hoyer et al.
PHYSIOLOGICAL REPORTS (2020)
Growth hormone signaling and action in obese versus lean human subjects
Morten Lyng Hogild et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes
Vishva M. Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: A randomized controlled crossover trial
Astrid Johannesson Hjelholt et al.
MOLECULAR METABOLISM (2019)
Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases
Wenqiang He et al.
ENDOCRINE (2019)
Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
Alessia Cozzolino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
IGF1 receptor signaling pathways
Fumihiko Hakuno et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Human adipose tissue protein analyses using capillary western blot technology
Jin Lu et al.
NUTRITION & DIABETES (2018)
Substrate Metabolism and Insulin Sensitivity During Fasting in Obese Human Subjects: Impact of GH Blockade
Morten Hogild Pedersen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
How to Measure Adipose Tissue Insulin Sensitivity
Esben Sondergaard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Evolution of Glucose Tolerance After Treatment of Acromegaly: A Study in 57 Patients
C. Jonas et al.
HORMONE AND METABOLIC RESEARCH (2016)
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment
Jakob Dal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
GAPDH and β-actin protein decreases with aging, making Stain-Free technology a superior loading control in Western blotting of human skeletal muscle
Andreas Vigelso et al.
JOURNAL OF APPLIED PHYSIOLOGY (2015)
Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment
Carlos M. Reyes-Vidal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity
B. Nellemann et al.
ACTA PHYSIOLOGICA (2014)
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
Andrea Giustina et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations
Martin Bidlingmaier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
S. J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Thomas Svava Nielsen et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
Orsalia Alexopoulou et al.
PITUITARY (2014)
Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved
Yuka Kinoshita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
Sandrine Fieffe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Acute Peripheral Metabolic Effects of Intraarterial Leg Infusion of Somatostatin in Healthy Young Men
Thomas Krusenstjerna-Hafstrom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis
D. O. Okorodudu et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Moller et al.
ENDOCRINE REVIEWS (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Impact of Somatostatin Analogs Versus Surgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Impact of Fasting on Growth Hormone Signaling and Action in Muscle and Fat
Louise Moller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Free Fatty Acids Inhibit Growth Hormone/Signal Transducer and Activator of Transcription-5 Signaling in Human Muscle: A Potential Feedback Mechanism
Niels Moller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Growth hormone signaling in vivo in human muscle and adipose tissue: Impact of insulin, substrate background, and growth hormone receptor blockade
Charlotte Nielsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly
Pamela U. Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue -: Mechanism for growth hormone-mediated insulin resistance
Juan-Pablo del Rincon et al.
DIABETES (2007)
Analysis of lipolytic protein trafficking and interactions in adipocytes
James G. Granneman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion:: An in vitro study on isolated human pancreatic islets
Vandana Singh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus
Jens O. L. Jorgensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN
Cullen M. Taniguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Consensus statement: medical management of acromegaly
S Melmed et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Increased p85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess
LA Barbour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity
FP Dominici et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue
C Kurlawalla-Martinez et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion
N Jessen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
B Stiles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
K Ueki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment
Roberto Baldelli et al.
CLINICAL ENDOCRINOLOGY (2003)
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
LY Rui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly
JJ Kopchick et al.
ENDOCRINE REVIEWS (2002)
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice
B Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
S Nielsen et al.
DIABETES (2001)
Regional lean body mass and resting energy expenditure in non-obese adults
MJ Müller et al.
EUROPEAN JOURNAL OF NUTRITION (2001)